They better not be hoping to completely launch a new drug which will involve P&T as it will be an epic fail. So many reps have now been banned from the inside of the hospitals due to this wonderful slap in the face increase that the name Mallinckrodt in the eyes of the pharmaceutical hospital environment is mud.
Don't worry they we offer contracting. New product will be super pricey but you get 8 cents off of an ofirmev vial. Of course that is if they keep you if they buy a new company.
New drug is Xartemis!! They are getting rid of most of the sales force that sells it. So guess who will pick it up??? Us!! Can't wait!!!
Well that is one drug we won't be selling and that has been officially confirmed thank Goodness. Many of us thought we potentially would be selling it, but that isn't going to happen. We are now just facing the possibility of acquiring a new or existing drug and hopefully it's a great existing product. If it requires P&T formulary acceptance, Mallinckrodt is in for a rude awakening.
